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Purpose: To compare the results of prophylactic pars plana 
vitrectomy with barrier laser photocoagulation in treatment of 
acute retinal necrosis (ARN).
Patients and Methods: Fifteen ARN patients were retrospectively 
included in this study. At presentation, all patients had severe 
vitreous involvement without any detectable break or retinal 
detachment (RD), either in funduscopy or echography exams. All 
patients received intravenous acyclovir 2 g/daily for two weeks. 
Eight patients underwent prophylactic vitrectomy and seven 
patients underwent barrier laser photocoagulation after resolution 
of vitritis. Visual and structural outcomes were compared between 
the two groups.
Results: In eight vitrectomized patients, one patient (12.5  %) 
experienced RD. The mean best corrected visual acuity (BCVA) 
improved significantly in this group (P  = 0.027). Among seven 
patients undergoing barrier laser photocoagulation, 3 patients 
(43 %) developed RD and BCVA improvement was not significant 
(P  = 0.207). Comparison between the two groups did not show 
any statistically significant benefit when comparing post treatment 
BCVA (P = 0.59) or RD prevention (P = 0.282).
Conclusion: Early prophylactic vitrectomy, in the course of ARN 
has been suggested as a useful method in preventing RD and 
improving the visual outcome, but the results of the present study 
did not indicate any significant benefit for vitrectomy compared to 
barrier laser photocoagulation. Further studies with larger sample 
size are recommended to compare these two methods of treatment.
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Introduction
Acute retinal necrosis (ARN) is an uncommon 
disease that may affect one or both eyes 
and result in blindness. Varicella Zoster 
Virus (VZV), Epstein Bar Virus (EBV), 
Herpes Simplex Virus (HSV), and rarely 
Cytomegalovirus (CMV) are implicated in the 
pathogenesis of ARN 1-8. The clinical features 
of ARN include peripheral patchy necrotizing 
retinitis that quickly becomes confluent, 
occlusive retinal vasculitis and inflammation 
in both anterior and posterior segments 9-15. 
Secondary retinal atrophy may cause multiple 
retinal breaks leading to retinal detachment 
(RD) in up to 85 % of patients 16-19. 
Prophylactic laser photocoagulation posterior 
to retinitis patches has been advocated to 
prevent RD, but it is limited by vitreous 
opacity caused by severe inflammation 
in these patients 16-23.There is no general 
consensus on indications and efficacy of pars 
plana vitrectomy in ARN patients. 
The aim of the present study was to compare 
the outcomes between prophylactic vitrectomy 
and prophylactic laser photocoagulation in 
patients with acute retinal necrosis.
Patients and Methods
In this retrospective study the treatment results 
of fifteen immunocompetent patients with the 
diagnosis of ARN in one eye treated in the 
emergency ward of Farabi Eye Hospital, Tehran, 
Iran, between January 2015 and November 
2018 were evaluated. All participants gave 
informed consent before their data was used in 
the present study and the study was approved 
by the ethics committee of Tehran University 
of Medical Sciences, Tehran, Iran. All patients 
had severe cloudy media due to severe 
vitreous inflammation, but neither funduscopy 
nor echography showed any sign of RD in any 
patient. ARN diagnosis was made clinically 
according to the American Uveitis Society 
diagnostic criteria 19. All patients received 
antiviral therapy consisting of intravenous 
acyclovir 15 mg/kg, prescribed three times per 
day for seven days followed by oral acyclovir 
800 mg five times a day for 3 months 20. Oral 
prednisolone (1 mg/kg) was also administered 
in active phase. If surgery was considered, 
corticosteroid was stopped due to lack of 
severe inflammation in silicone filled operated 
eyes. 
In the first group 8 patients underwent pars 
plana vitrectomy within 10 days of ARN 
diagnosis. In the second group 7 patients 
underwent three rows of barrier laser 
photocoagulation posterior to retinal necrosis 
area after partial resolution of vitritis and 
media opacity. 
Vitrectomy was performed using 23 gauge 
standard three-port system and moderate to 
Table1: Demographic findings and visual outcome of patients entering the study
Variable Vitrectomized Non-vitrectomized P value
Mean age 44.6 years 39 years 0.49
Sex (Female/Male) 3/5 2/6 0.59
Mean best pretreatment  corrected 
visual acuity (LogMAR)
- 2.43 - 2.47 0.92
Mean best post treatment  corrected 
visual acuity (LogMAR)
- 1.5 - 2.26 0.59
Retinal detachment 12.5 % (One patient) 50 % (Four patients) 0.282
A Comparison between Prophylactic Vitrectomy and Laser Photocoagulation Tabatabaei et al.
Journal of Ophthalmic and Optometric Sciences. Volume 2, Number 3, Summer 2018. 3
This work is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)
severe cataracts were extracted. Posterior 
vitreous detachment (PVD) was induced and 
peripheral shaving was performed after core 
vitrectomy. In four patients retinal breaks 
were seen intraoperatively at the border of 
necrosis (patients 1, 2, 4 and 7 in table 2). In 
these patients laser photocoagulation was 
performed around the breaks. Also three 
rows of laser barrier spots posterior to retinal 
necrotic area (even if no break was found) 
were implemented. Tamponade with silicone 
oil (viscosity 5700 cs) was performed after air-
fluid exchange.
Statistical Analysis
Statistical analysis was performed using SPSS 
software version 20 (Armonk, NY: IBM 
Corp.). Data normality was assessed using 
Shapiro-Wilk test.  Mann-Whitney and Chi 
square tests were used to assess age, gender 
and retinal detachment distributions. Signed 
ranks test was applied to compare visual 
improvement before and after treatment in 
both vitrectomized and non-vitrectomized 
groups. The repeated measure test was used 
to compare the trend of visual acuity changes 
between groups. P values less than 0.05 were 
considered statistically significant.
Results
In the present retrospective study fifteen 
medical records were reviewed. Patients’ 
demographic data are summarized in table 1. 
Follow-up time of the patients ranged from 
3 to 17 months with a mean follow-up of 
8.5 months. All vitrectomized eyes except 
one had attached retina until last follow-up. 
One patient showed tractional membrane 
causing progressive RD developed in nasal 
retina 3 months after surgery. This patient 
was scheduled for a second surgery (Patient 
4, table 2).  The mean corrected visual 
acuity of patients improved significantly in 
vitrectomized group (P = 0.027), but this 
improvement was not statistically significant 
in non-vitrectomized patients undergoing 
barrier laser photocoagulation (P = 0.207).
Comparison of post treatment visual acuity 
between the two groups was insignificant 
(P  = 0.59).  In non-vitrectomized group, three 
patients (43 %) developed RD and underwent 
vitrectomy (Table 3). The difference between 
the number of patients developing post 
treatment RD in two groups of patients was 
not statistically significant (P = 0.282). 
Discussion
Complicated RD develops in 50-85% of cases 
Table 2: Characteristics of vitrectomized patients entering the study






1 Male 32 5 LP LP
2 Male 35 9 LP HM
3 Male 30 2 FC 3 meter 20/200
4 Male 50 4 HM HM
5 Female 30 5 FC 1 meter FC 2 meter
6 Male 70 6 FC 2 meter FC 4 meter
7 Female 65 7 LP LP
8 Female 45 4 FC 2 meter 20/200
LP: Light perception; HM: Hand motion; FC: Finger counting
A Comparison between Prophylactic Vitrectomy and Laser PhotocoagulationTabatabaei et al.
Journal of Ophthalmic and Optometric Sciences. Volume 2, Number 3, Summer 2018.
This work is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)
4
with ARN syndrome 1,2,13,16,18,21 and a low 
reattachment rate is present even with early 
surgery 13,21,22. Retinal laser photocoagulation 
and vitrectomy are the strategies suggested to 
reduce the rate of RD 10-18. 
Lau et al., 14 have reported a decrease in the rate 
of RD by more than half using prophylactic 
laser photocoagulation in patients with ARN 
14. If media opacity allows, confluent rows of 
laser photocoagulation posterior to necrotic 
retina might decrease the incidence of RD 
12,15,22-26.
Vitreous opacity may prevent careful 
examination of fundus and detection of 
breaks for photocoagulation. It is also 
difficult to obtain good laser effect in areas of 
exudation. The use of laser photocoagulation 
in management of ARN remains controversial. 
Laser photocoagulation has been found to 
be unhelpful in controlling the progression 
of retinitis in some trials 27. Also some 
studies have reported that prophylactic laser 
photocoagulation does not contribute to a 
lower detachment rate 28. In a study by Luo et 
al.,27 laser photocoagulation was performed in 
13 patients but necrosis did not improve and 
RD developed in all patients. In our study RD 
occurred in 3 patients (43 %) out of 7 patients 
undergoing laser photocoagulation. 
Some trials have reported the efficacy of 
prophylactic vitrectomy in prevention of RD in 
ARN patients, but controversy still exists about 
the usefulness of vitrectomy in helping these 
patients and there is no general consensus on 
surgical indications 18,29. Ishida et al.,29 in their 
study concluded that prophylactic vitrectomy is 
effective in preventing the development of RD 
when necrotic lesions do not extend beyond the 
midperiphery. They indicated that the extent of 
necrotizing retinitis at the initial presentation 
following prophylactic vitrectomy can be used 
as a parameter to predict the development of 
RD. Lou et al., 27 in their study emphasized 
that prophylactic vitrectomy can prevent RD 
and improve the prognosis of ARN, making it 
an option for cases with rapidly progressing 
necrosis despite antiviral treatment as well as 
cases with moderate to extensive necrosis and 
severe vitreous opacity. In some other reports 
vitrectomy has been found to be useless in 
improving ARN patient’ vision 28. 
In the present study, prophylactic vitrectomy 
did not show a statistically significant 
difference with laser photocoagulation in 
improving visual outcomes. Besides the low 
sample size, other reasons which may cause 
low vision improvement including optic 
atrophy, macular ischemia and epiretinal 
Table 3: Characteristics of non-vitrectomized patients entering the study
Case Gender Age Initial VA Final VA Retinal examination




RD after 2 weeks
2 Male 32 FC 2 meter FC 3 meter Retina remained attached
3 Female 50 LP HM RD after 1 month
4 Male 45 FC 1 meter FC 2 meter Retina remained attached
5 Male 33 HM FC 1 meter RD after 2 months
6 Male 45 1/10 2/10 Retina remained attached
7 Male 32 2/10 2/10 Retina remained attached
LP: Light perception; HM: Hand motion; FC: Finger counting
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proliferation 30, might have caused the lack 
of significant difference in our outcomes. 
One of the operated patients in the present 
study developed progressive tractional RD 
and a second surgery was necessary for 
retinal attachment. Also four patients with 
no significant vision improvement developed 
optic atrophy at their last follow-up visit. 
Similar to these findings, Iwahashi-Shima et 
al., 30 reported that prophylactic vitrectomy 
was not correlated with the visual prognosis. 
They suggested that irreversible damage to 
the retina and optic nerve before antiviral 
treatment strongly affects the visual prognosis.
In the present study, prophylactic vitrectomy 
reduced the incidence of RD (12.5 % 
in operated eyes versus 43 % in the 
photocoagulation group), but the difference 
was not statistically significant (P = 0.282), 
possibly due to the low sample size. Other 
studies have reported that prophylactic 
vitrectomy might prevent retinal detachment, 
but could not improve the mean final visual 
acuity 13.
Limitations of the present study were the small 
number of patients in groups, retrospective 
design of the study and the fact that vision in 
eyes with retained silicone oil may improve 
after silicone removal, which was not followed 
in this study. 
Conclusion
Early prophylactic vitrectomy, in the course of 
ARN has been suggested as a useful method 
in preventing RD and improving the visual 
outcome, but the results of the present study did 
not indicate a significant benefit for vitrectomy 
compared to barrier laser photocoagulation. 
Further studies with larger sample sizes are 
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